block randomisation Search Results


block randomisation and allocation of patients to treatment and control groups  (Klinge Pharma GmbH)
90
Klinge Pharma GmbH block randomisation and allocation of patients to treatment and control groups
Block Randomisation And Allocation Of Patients To Treatment And Control Groups, supplied by Klinge Pharma GmbH, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/block+randomisation/pmc07144685-211-17-23?v=Klinge+Pharma+GmbH
Average 90 stars, based on 1 article reviews
block randomisation and allocation of patients to treatment and control groups - by Bioz Stars, 2026-08
90/100 stars
  Buy from Supplier
block randomisation  (Intersect Australia Ltd)
90
Intersect Australia Ltd block randomisation
Block Randomisation, supplied by Intersect Australia Ltd, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/block+randomisation/pm39126838-285-40-32?v=Intersect+Australia+Ltd
Average 90 stars, based on 1 article reviews
block randomisation - by Bioz Stars, 2026-08
90/100 stars
  Buy from Supplier
block balanced randomisation codes  (Catalent Pharma Solutions)
90
Catalent Pharma Solutions block balanced randomisation codes
Block Balanced Randomisation Codes, supplied by Catalent Pharma Solutions, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/block+randomisation/pmc06537970__bmjopen___2019___029554__draft_revisions-707-21-32?v=Catalent+Pharma+Solutions
Average 90 stars, based on 1 article reviews
block balanced randomisation codes - by Bioz Stars, 2026-08
90/100 stars
  Buy from Supplier
digital en-block randomisation system  (EBD Group)
90
EBD Group digital en-block randomisation system
Digital En Block Randomisation System, supplied by EBD Group, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/block+randomisation/nct05521867-22-20-11?v=EBD+Group
Average 90 stars, based on 1 article reviews
digital en-block randomisation system - by Bioz Stars, 2026-08
90/100 stars
  Buy from Supplier
block randomisation schedules  (Endpoint Clinical)
90
Endpoint Clinical block randomisation schedules
Block Randomisation Schedules, supplied by Endpoint Clinical, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/block+randomisation/10__1016_slash_s0140___6736_ascii40_23_ascii41_00061___2-62-0-27?v=Endpoint+Clinical
Average 90 stars, based on 1 article reviews
block randomisation schedules - by Bioz Stars, 2026-08
90/100 stars
  Buy from Supplier
computer-generated variable block randomisation  (Prehab Technologies LLC)
90
Prehab Technologies LLC computer-generated variable block randomisation
Computer Generated Variable Block Randomisation, supplied by Prehab Technologies LLC, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/block+randomisation/pmc06318540-131-13-19?v=Prehab+Technologies+LLC
Average 90 stars, based on 1 article reviews
computer-generated variable block randomisation - by Bioz Stars, 2026-08
90/100 stars
  Buy from Supplier
balanced block randomisation  (Tillotts Pharma AG)
90
Tillotts Pharma AG balanced block randomisation
Characteristics of included studies [ordered by study ID]
Balanced Block Randomisation, supplied by Tillotts Pharma AG, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/block+randomisation/pmc04170890-309-2-8?v=Tillotts+Pharma+AG
Average 90 stars, based on 1 article reviews
balanced block randomisation - by Bioz Stars, 2026-08
90/100 stars
  Buy from Supplier
block-balanced randomisation  (StatsDirect ltd)
90
StatsDirect ltd block-balanced randomisation
Characteristics of included studies [ordered by study ID]
Block Balanced Randomisation, supplied by StatsDirect ltd, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/block+randomisation/pmc06429886-59-1-10?v=StatsDirect+ltd
Average 90 stars, based on 1 article reviews
block-balanced randomisation - by Bioz Stars, 2026-08
90/100 stars
  Buy from Supplier
block randomisation list (block size 12)  (StatsDirect ltd)
90
StatsDirect ltd block randomisation list (block size 12)
Protocol amendments
Block Randomisation List (Block Size 12), supplied by StatsDirect ltd, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/block+randomisation/pmc07754630-88-1-11?v=StatsDirect+ltd
Average 90 stars, based on 1 article reviews
block randomisation list (block size 12) - by Bioz Stars, 2026-08
90/100 stars
  Buy from Supplier
computer-generated participant identification number and randomisation schedule with block randomisation  (Veristat Inc)
90
Veristat Inc computer-generated participant identification number and randomisation schedule with block randomisation
Protocol amendments
Computer Generated Participant Identification Number And Randomisation Schedule With Block Randomisation, supplied by Veristat Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/block+randomisation/10__1016_slash_s0140___6736_ascii40_23_ascii41_02190___6-67-22-8?v=Veristat+Inc
Average 90 stars, based on 1 article reviews
computer-generated participant identification number and randomisation schedule with block randomisation - by Bioz Stars, 2026-08
90/100 stars
  Buy from Supplier
clinstat block randomisation  (ClinStat GmbH)
90
ClinStat GmbH clinstat block randomisation
Protocol amendments
Clinstat Block Randomisation, supplied by ClinStat GmbH, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/block+randomisation/pm25939641-85-13-13?v=ClinStat+GmbH
Average 90 stars, based on 1 article reviews
clinstat block randomisation - by Bioz Stars, 2026-08
90/100 stars
  Buy from Supplier
randomised block design  (Cenibra GmbH)
90
Cenibra GmbH randomised block design
Protocol amendments
Randomised Block Design, supplied by Cenibra GmbH, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/block+randomisation/10__1016_slash_j__foreco__2012__09__019-1-2-9?v=Cenibra+GmbH
Average 90 stars, based on 1 article reviews
randomised block design - by Bioz Stars, 2026-08
90/100 stars
  Buy from Supplier

Image Search Results


Characteristics of included studies [ordered by study ID]

Journal: The Cochrane database of systematic reviews

Article Title: Omega 3 fatty acids for prevention and treatment of cardiovascular disease

doi: 10.1002/14651858.CD003177.pub2

Figure Lengend Snippet: Characteristics of included studies [ordered by study ID]

Article Snippet: Methods , Randomisation: balanced block randomisation performed by Tillotts Pharma Allocation concealment: Done Participants masked: yes Providers masked: yes Outcome assessors masked: yes Summary risk of bias: low , .

Techniques: Blocking Assay, Control, Activity Assay

Journal: The Cochrane database of systematic reviews

Article Title: Omega 3 fatty acids for prevention and treatment of cardiovascular disease

doi: 10.1002/14651858.CD003177.pub2

Figure Lengend Snippet:

Article Snippet: Methods , Randomisation: balanced block randomisation performed by Tillotts Pharma Allocation concealment: Done Participants masked: yes Providers masked: yes Outcome assessors masked: yes Summary risk of bias: low , .

Techniques: Control, Capsules, Clinical Proteomics

Journal: The Cochrane database of systematic reviews

Article Title: Omega 3 fatty acids for prevention and treatment of cardiovascular disease

doi: 10.1002/14651858.CD003177.pub2

Figure Lengend Snippet:

Article Snippet: Methods , Randomisation: balanced block randomisation performed by Tillotts Pharma Allocation concealment: Done Participants masked: yes Providers masked: yes Outcome assessors masked: yes Summary risk of bias: low , .

Techniques: Control, Capsules

Journal: The Cochrane database of systematic reviews

Article Title: Omega 3 fatty acids for prevention and treatment of cardiovascular disease

doi: 10.1002/14651858.CD003177.pub2

Figure Lengend Snippet:

Article Snippet: Methods , Randomisation: balanced block randomisation performed by Tillotts Pharma Allocation concealment: Done Participants masked: yes Providers masked: yes Outcome assessors masked: yes Summary risk of bias: low , .

Techniques: Blocking Assay, Control, Capsules, Labeling

Journal: The Cochrane database of systematic reviews

Article Title: Omega 3 fatty acids for prevention and treatment of cardiovascular disease

doi: 10.1002/14651858.CD003177.pub2

Figure Lengend Snippet:

Article Snippet: Methods , Randomisation: balanced block randomisation performed by Tillotts Pharma Allocation concealment: Done Participants masked: yes Providers masked: yes Outcome assessors masked: yes Summary risk of bias: low , .

Techniques: Generated, Control

Journal: The Cochrane database of systematic reviews

Article Title: Omega 3 fatty acids for prevention and treatment of cardiovascular disease

doi: 10.1002/14651858.CD003177.pub2

Figure Lengend Snippet:

Article Snippet: Methods , Randomisation: balanced block randomisation performed by Tillotts Pharma Allocation concealment: Done Participants masked: yes Providers masked: yes Outcome assessors masked: yes Summary risk of bias: low , .

Techniques: Control, Capsules

Journal: The Cochrane database of systematic reviews

Article Title: Omega 3 fatty acids for prevention and treatment of cardiovascular disease

doi: 10.1002/14651858.CD003177.pub2

Figure Lengend Snippet:

Article Snippet: Methods , Randomisation: balanced block randomisation performed by Tillotts Pharma Allocation concealment: Done Participants masked: yes Providers masked: yes Outcome assessors masked: yes Summary risk of bias: low , .

Techniques: Blocking Assay, Control

Journal: The Cochrane database of systematic reviews

Article Title: Omega 3 fatty acids for prevention and treatment of cardiovascular disease

doi: 10.1002/14651858.CD003177.pub2

Figure Lengend Snippet:

Article Snippet: Methods , Randomisation: balanced block randomisation performed by Tillotts Pharma Allocation concealment: Done Participants masked: yes Providers masked: yes Outcome assessors masked: yes Summary risk of bias: low , .

Techniques: Control

Journal: The Cochrane database of systematic reviews

Article Title: Omega 3 fatty acids for prevention and treatment of cardiovascular disease

doi: 10.1002/14651858.CD003177.pub2

Figure Lengend Snippet:

Article Snippet: Methods , Randomisation: balanced block randomisation performed by Tillotts Pharma Allocation concealment: Done Participants masked: yes Providers masked: yes Outcome assessors masked: yes Summary risk of bias: low , .

Techniques: Control, Capsules

Journal: The Cochrane database of systematic reviews

Article Title: Omega 3 fatty acids for prevention and treatment of cardiovascular disease

doi: 10.1002/14651858.CD003177.pub2

Figure Lengend Snippet:

Article Snippet: Methods , Randomisation: balanced block randomisation performed by Tillotts Pharma Allocation concealment: Done Participants masked: yes Providers masked: yes Outcome assessors masked: yes Summary risk of bias: low , .

Techniques: Control, Capsules

Journal: The Cochrane database of systematic reviews

Article Title: Omega 3 fatty acids for prevention and treatment of cardiovascular disease

doi: 10.1002/14651858.CD003177.pub2

Figure Lengend Snippet:

Article Snippet: Methods , Randomisation: balanced block randomisation performed by Tillotts Pharma Allocation concealment: Done Participants masked: yes Providers masked: yes Outcome assessors masked: yes Summary risk of bias: low , .

Techniques: Sequencing, Control, Capsules

Journal: The Cochrane database of systematic reviews

Article Title: Omega 3 fatty acids for prevention and treatment of cardiovascular disease

doi: 10.1002/14651858.CD003177.pub2

Figure Lengend Snippet:

Article Snippet: Methods , Randomisation: balanced block randomisation performed by Tillotts Pharma Allocation concealment: Done Participants masked: yes Providers masked: yes Outcome assessors masked: yes Summary risk of bias: low , .

Techniques: Control

Journal: The Cochrane database of systematic reviews

Article Title: Omega 3 fatty acids for prevention and treatment of cardiovascular disease

doi: 10.1002/14651858.CD003177.pub2

Figure Lengend Snippet:

Article Snippet: Methods , Randomisation: balanced block randomisation performed by Tillotts Pharma Allocation concealment: Done Participants masked: yes Providers masked: yes Outcome assessors masked: yes Summary risk of bias: low , .

Techniques: Generated, Control, Capsules

Journal: The Cochrane database of systematic reviews

Article Title: Omega 3 fatty acids for prevention and treatment of cardiovascular disease

doi: 10.1002/14651858.CD003177.pub2

Figure Lengend Snippet:

Article Snippet: Methods , Randomisation: balanced block randomisation performed by Tillotts Pharma Allocation concealment: Done Participants masked: yes Providers masked: yes Outcome assessors masked: yes Summary risk of bias: low , .

Techniques: Generated, Control, Capsules

Journal: The Cochrane database of systematic reviews

Article Title: Omega 3 fatty acids for prevention and treatment of cardiovascular disease

doi: 10.1002/14651858.CD003177.pub2

Figure Lengend Snippet:

Article Snippet: Methods , Randomisation: balanced block randomisation performed by Tillotts Pharma Allocation concealment: Done Participants masked: yes Providers masked: yes Outcome assessors masked: yes Summary risk of bias: low , .

Techniques: Control, Capsules

Journal: The Cochrane database of systematic reviews

Article Title: Omega 3 fatty acids for prevention and treatment of cardiovascular disease

doi: 10.1002/14651858.CD003177.pub2

Figure Lengend Snippet:

Article Snippet: Methods , Randomisation: balanced block randomisation performed by Tillotts Pharma Allocation concealment: Done Participants masked: yes Providers masked: yes Outcome assessors masked: yes Summary risk of bias: low , .

Techniques: Control, Capsules

Journal: The Cochrane database of systematic reviews

Article Title: Omega 3 fatty acids for prevention and treatment of cardiovascular disease

doi: 10.1002/14651858.CD003177.pub2

Figure Lengend Snippet:

Article Snippet: Methods , Randomisation: balanced block randomisation performed by Tillotts Pharma Allocation concealment: Done Participants masked: yes Providers masked: yes Outcome assessors masked: yes Summary risk of bias: low , .

Techniques: Control, Capsules, Membrane

Journal: The Cochrane database of systematic reviews

Article Title: Omega 3 fatty acids for prevention and treatment of cardiovascular disease

doi: 10.1002/14651858.CD003177.pub2

Figure Lengend Snippet:

Article Snippet: Methods , Randomisation: balanced block randomisation performed by Tillotts Pharma Allocation concealment: Done Participants masked: yes Providers masked: yes Outcome assessors masked: yes Summary risk of bias: low , .

Techniques: Control, Membrane, Activity Assay

Journal: The Cochrane database of systematic reviews

Article Title: Omega 3 fatty acids for prevention and treatment of cardiovascular disease

doi: 10.1002/14651858.CD003177.pub2

Figure Lengend Snippet:

Article Snippet: Methods , Randomisation: balanced block randomisation performed by Tillotts Pharma Allocation concealment: Done Participants masked: yes Providers masked: yes Outcome assessors masked: yes Summary risk of bias: low , .

Techniques: Control, Capsules

Journal: The Cochrane database of systematic reviews

Article Title: Omega 3 fatty acids for prevention and treatment of cardiovascular disease

doi: 10.1002/14651858.CD003177.pub2

Figure Lengend Snippet:

Article Snippet: Methods , Randomisation: balanced block randomisation performed by Tillotts Pharma Allocation concealment: Done Participants masked: yes Providers masked: yes Outcome assessors masked: yes Summary risk of bias: low , .

Techniques: Capsules, Control, Clinical Proteomics

Journal: The Cochrane database of systematic reviews

Article Title: Omega 3 fatty acids for prevention and treatment of cardiovascular disease

doi: 10.1002/14651858.CD003177.pub2

Figure Lengend Snippet:

Article Snippet: Methods , Randomisation: balanced block randomisation performed by Tillotts Pharma Allocation concealment: Done Participants masked: yes Providers masked: yes Outcome assessors masked: yes Summary risk of bias: low , .

Techniques: Generated, Control, Capsules

Journal: The Cochrane database of systematic reviews

Article Title: Omega 3 fatty acids for prevention and treatment of cardiovascular disease

doi: 10.1002/14651858.CD003177.pub2

Figure Lengend Snippet:

Article Snippet: Methods , Randomisation: balanced block randomisation performed by Tillotts Pharma Allocation concealment: Done Participants masked: yes Providers masked: yes Outcome assessors masked: yes Summary risk of bias: low , .

Techniques: Software, Control, Capsules, Membrane

Journal: The Cochrane database of systematic reviews

Article Title: Omega 3 fatty acids for prevention and treatment of cardiovascular disease

doi: 10.1002/14651858.CD003177.pub2

Figure Lengend Snippet:

Article Snippet: Methods , Randomisation: balanced block randomisation performed by Tillotts Pharma Allocation concealment: Done Participants masked: yes Providers masked: yes Outcome assessors masked: yes Summary risk of bias: low , .

Techniques: Software, Control, Capsules, Membrane

Journal: The Cochrane database of systematic reviews

Article Title: Omega 3 fatty acids for prevention and treatment of cardiovascular disease

doi: 10.1002/14651858.CD003177.pub2

Figure Lengend Snippet:

Article Snippet: Methods , Randomisation: balanced block randomisation performed by Tillotts Pharma Allocation concealment: Done Participants masked: yes Providers masked: yes Outcome assessors masked: yes Summary risk of bias: low , .

Techniques: Control, Capsules, Clinical Proteomics

Journal: The Cochrane database of systematic reviews

Article Title: Omega 3 fatty acids for prevention and treatment of cardiovascular disease

doi: 10.1002/14651858.CD003177.pub2

Figure Lengend Snippet:

Article Snippet: Methods , Randomisation: balanced block randomisation performed by Tillotts Pharma Allocation concealment: Done Participants masked: yes Providers masked: yes Outcome assessors masked: yes Summary risk of bias: low , .

Techniques: Control, Capsules, Clinical Proteomics

Journal: The Cochrane database of systematic reviews

Article Title: Omega 3 fatty acids for prevention and treatment of cardiovascular disease

doi: 10.1002/14651858.CD003177.pub2

Figure Lengend Snippet:

Article Snippet: Methods , Randomisation: balanced block randomisation performed by Tillotts Pharma Allocation concealment: Done Participants masked: yes Providers masked: yes Outcome assessors masked: yes Summary risk of bias: low , .

Techniques: Blocking Assay, Control, Capsules

Journal: The Cochrane database of systematic reviews

Article Title: Omega 3 fatty acids for prevention and treatment of cardiovascular disease

doi: 10.1002/14651858.CD003177.pub2

Figure Lengend Snippet:

Article Snippet: Methods , Randomisation: balanced block randomisation performed by Tillotts Pharma Allocation concealment: Done Participants masked: yes Providers masked: yes Outcome assessors masked: yes Summary risk of bias: low , .

Techniques: Control, Capsules

Journal: The Cochrane database of systematic reviews

Article Title: Omega 3 fatty acids for prevention and treatment of cardiovascular disease

doi: 10.1002/14651858.CD003177.pub2

Figure Lengend Snippet:

Article Snippet: Methods , Randomisation: balanced block randomisation performed by Tillotts Pharma Allocation concealment: Done Participants masked: yes Providers masked: yes Outcome assessors masked: yes Summary risk of bias: low , .

Techniques: Control

Journal: The Cochrane database of systematic reviews

Article Title: Omega 3 fatty acids for prevention and treatment of cardiovascular disease

doi: 10.1002/14651858.CD003177.pub2

Figure Lengend Snippet:

Article Snippet: Methods , Randomisation: balanced block randomisation performed by Tillotts Pharma Allocation concealment: Done Participants masked: yes Providers masked: yes Outcome assessors masked: yes Summary risk of bias: low , .

Techniques: Control

Journal: The Cochrane database of systematic reviews

Article Title: Omega 3 fatty acids for prevention and treatment of cardiovascular disease

doi: 10.1002/14651858.CD003177.pub2

Figure Lengend Snippet:

Article Snippet: Methods , Randomisation: balanced block randomisation performed by Tillotts Pharma Allocation concealment: Done Participants masked: yes Providers masked: yes Outcome assessors masked: yes Summary risk of bias: low , .

Techniques: Capsules, Control

Journal: The Cochrane database of systematic reviews

Article Title: Omega 3 fatty acids for prevention and treatment of cardiovascular disease

doi: 10.1002/14651858.CD003177.pub2

Figure Lengend Snippet:

Article Snippet: Methods , Randomisation: balanced block randomisation performed by Tillotts Pharma Allocation concealment: Done Participants masked: yes Providers masked: yes Outcome assessors masked: yes Summary risk of bias: low , .

Techniques: Control, Capsules

Journal: The Cochrane database of systematic reviews

Article Title: Omega 3 fatty acids for prevention and treatment of cardiovascular disease

doi: 10.1002/14651858.CD003177.pub2

Figure Lengend Snippet:

Article Snippet: Methods , Randomisation: balanced block randomisation performed by Tillotts Pharma Allocation concealment: Done Participants masked: yes Providers masked: yes Outcome assessors masked: yes Summary risk of bias: low , .

Techniques: Generated, Produced, Filtration, Control, Emulsion

Journal: The Cochrane database of systematic reviews

Article Title: Omega 3 fatty acids for prevention and treatment of cardiovascular disease

doi: 10.1002/14651858.CD003177.pub2

Figure Lengend Snippet:

Article Snippet: Methods , Randomisation: balanced block randomisation performed by Tillotts Pharma Allocation concealment: Done Participants masked: yes Providers masked: yes Outcome assessors masked: yes Summary risk of bias: low , .

Techniques: Control, Clinical Proteomics

Journal: The Cochrane database of systematic reviews

Article Title: Omega 3 fatty acids for prevention and treatment of cardiovascular disease

doi: 10.1002/14651858.CD003177.pub2

Figure Lengend Snippet:

Article Snippet: Methods , Randomisation: balanced block randomisation performed by Tillotts Pharma Allocation concealment: Done Participants masked: yes Providers masked: yes Outcome assessors masked: yes Summary risk of bias: low , .

Techniques: Control, Capsules

Journal: The Cochrane database of systematic reviews

Article Title: Omega 3 fatty acids for prevention and treatment of cardiovascular disease

doi: 10.1002/14651858.CD003177.pub2

Figure Lengend Snippet:

Article Snippet: Methods , Randomisation: balanced block randomisation performed by Tillotts Pharma Allocation concealment: Done Participants masked: yes Providers masked: yes Outcome assessors masked: yes Summary risk of bias: low , .

Techniques: Selection, Control, Capsules

Journal: The Cochrane database of systematic reviews

Article Title: Omega 3 fatty acids for prevention and treatment of cardiovascular disease

doi: 10.1002/14651858.CD003177.pub2

Figure Lengend Snippet:

Article Snippet: Methods , Randomisation: balanced block randomisation performed by Tillotts Pharma Allocation concealment: Done Participants masked: yes Providers masked: yes Outcome assessors masked: yes Summary risk of bias: low , .

Techniques: Labeling, Capsules, Control, Clinical Proteomics

Journal: The Cochrane database of systematic reviews

Article Title: Omega 3 fatty acids for prevention and treatment of cardiovascular disease

doi: 10.1002/14651858.CD003177.pub2

Figure Lengend Snippet:

Article Snippet: Methods , Randomisation: balanced block randomisation performed by Tillotts Pharma Allocation concealment: Done Participants masked: yes Providers masked: yes Outcome assessors masked: yes Summary risk of bias: low , .

Techniques: Control, Capsules, Clinical Proteomics

Journal: The Cochrane database of systematic reviews

Article Title: Omega 3 fatty acids for prevention and treatment of cardiovascular disease

doi: 10.1002/14651858.CD003177.pub2

Figure Lengend Snippet:

Article Snippet: Methods , Randomisation: balanced block randomisation performed by Tillotts Pharma Allocation concealment: Done Participants masked: yes Providers masked: yes Outcome assessors masked: yes Summary risk of bias: low , .

Techniques: Control, Capsules, Clinical Proteomics

Journal: The Cochrane database of systematic reviews

Article Title: Omega 3 fatty acids for prevention and treatment of cardiovascular disease

doi: 10.1002/14651858.CD003177.pub2

Figure Lengend Snippet:

Article Snippet: Methods , Randomisation: balanced block randomisation performed by Tillotts Pharma Allocation concealment: Done Participants masked: yes Providers masked: yes Outcome assessors masked: yes Summary risk of bias: low , .

Techniques: Control, Capsules

Journal: The Cochrane database of systematic reviews

Article Title: Omega 3 fatty acids for prevention and treatment of cardiovascular disease

doi: 10.1002/14651858.CD003177.pub2

Figure Lengend Snippet:

Article Snippet: Methods , Randomisation: balanced block randomisation performed by Tillotts Pharma Allocation concealment: Done Participants masked: yes Providers masked: yes Outcome assessors masked: yes Summary risk of bias: low , .

Techniques: Generated, Sequencing, Control, Capsules

Journal: The Cochrane database of systematic reviews

Article Title: Omega 3 fatty acids for prevention and treatment of cardiovascular disease

doi: 10.1002/14651858.CD003177.pub2

Figure Lengend Snippet:

Article Snippet: Methods , Randomisation: balanced block randomisation performed by Tillotts Pharma Allocation concealment: Done Participants masked: yes Providers masked: yes Outcome assessors masked: yes Summary risk of bias: low , .

Techniques: Clinical Proteomics, Control

Protocol amendments

Journal: BMJ Open

Article Title: TriMaster: randomised double-blind crossover study of a DPP4 inhibitor, SGLT2 inhibitor and thiazolidinedione as second-line or third-line therapy in patients with type 2 diabetes who have suboptimal glycaemic control on metformin treatment with or without a sulfonylurea—a MASTERMIND study protocol

doi: 10.1136/bmjopen-2020-042784

Figure Lengend Snippet: Protocol amendments

Article Snippet: A block randomisation list (block size 12) will be created using Statsdirect by the Trial Statistician and the randomisation seed recorded.

Techniques: Clarification Assay, Clinical Proteomics